FDA Inspection 1199699 — Hovione Limited
The FDA completed an inspection of Hovione Limited on Jan 20, 2023 in Ringaskiddy. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 20, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ringaskiddy (Ireland)